Summary
Updated Aug 30, 2026
Marie Milie Jones files SEC Form 4 reports at FEDERATED HERMES, INC. (FHI). 2 SEC Form 4 filings on record going back to 2025, most recently on 4 May 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Marie Milie Jones has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Marie Milie Jones files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul A. Uhlman - $5.46M of FHI open-market activity in the last 12 months
- Saker Anwar Nusseibeh - $2.57M of FHI open-market activity in the last 12 months
- Thomas R. Donahue - $1.71M of FHI open-market activity in the last 12 months
- Peter J. Germain - $1.18M of FHI open-market activity in the last 12 months
- Richard A. Novak - $882K of FHI open-market activity in the last 12 months
- John B. Fisher - $366K of FHI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Marie Milie Jones?
Marie Milie Jones is a corporate insider of FEDERATED HERMES, INC. (FHI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Marie Milie Jones last file a Form 4?
The most recent primary Form 4 on record is dated 4 May 2026, one of 2 filings going back to 2025.
Where can I see all of Marie Milie Jones's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Marie Milie Jones and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial